Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.9%
    Check dated 2025-06-19T19:54:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:21:51.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:08:30.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:24:00.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to head and neck cancer treatments, specifically mentioning Cisplatin, Carboplatin, and 5-Fluorouracil, while removing extensive details about a previous study involving pembrolizumab and epacadostat.
    Difference
    13%
    Check dated 2025-04-16T10:55:53.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 15, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T05:24:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.